The director and chief research scientist at Tisch MS Research Center of New York talked about a phase 2 data study on stem cell treatment for multiple sclerosis that was presented at the 2023 AAN Annual Meeting. [WATCH TIME: 7 minutes]
Saud A. Sadiq, MD, FAAN
Advertisement
Director and chief research scientist at Tisch MS Research Center of New York.
Articles by Saud A. Sadiq, MD, FAAN
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Approves Doxecitine and Doxribtimine Combination Therapy as First Treatment for Thymidine Kinase 2 Deficiency
2
New Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis Treatment
3
Jessica Neil, PA, on the Evolution of Patients With Headache
4
Surveying Global Nursing Needs for Patients With Generalized Myasthenia Gravis: Amy Perrin Ross, APN, MSN, CNRN, MSCN
5
